Effect of Exercises on Convergence Insufficiency in Individuals With Temporomandibular Disorders

March 5, 2024 updated by: Daniela Ap. Biasotto-Gonzalez, University of Nove de Julho

Effect of Exercises on Convergence Insufficiency in Individuals With Temporomandibular Disorders: Clinical, Randomized, Blinded Trial

Temporomandibular Disorder is a disorder that involves the muscles of mastication, the temporomandibular joint (TMJ), and associated structures. Convergence insufficiency (CI) is characterized by the inability of the eyes to perform the eye adduction movement together, to focus on a nearby object. Studies show that there is a relationship between the presence of TMD and its signs and symptoms in patients with convergence insufficiency. Given this, the research question of this clinical trial is whether the effect of oculomotor therapy would be effective in improving the signs and symptoms of Temporomandibular Disorder. The design of this research is a Clinical Trial, Randomized and Blind. It will be divided into two moments: evaluation and intervention. The evaluations will be carried out using the Diagnostic Criteria for Temporomandibular Disorders: Fonseca Anamnestic Index (IAF), Clinical Protocol and Assessment Instruments (DC/TMD), Mandibular function Impairment Questionnaire (MFIQ), Numerical Pain Scale (END), Convergence Test, Meersseman Test and Convergence insufficiency symptom Survey (CISS). Individuals will be randomized into 2 groups: Group A (Treatment for Temporomandibular Disorder) and Group B (Treatment Oculomotor plus Treatment for Temporomandibular Disorder). Both groups will receive physiotherapeutic treatment for 12 weeks. Patients will be reassessed shortly after treatment, 3 and 6 months later. For data analysis, the statistical significance considered will be p<0.05.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • SP
      • Mogi das Cruzes, SP, Brazil, 08771-910
        • Recruiting
        • Daniela Aparecida Biasotto Gonzalez
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 18 and 60 years;
  • Presence of pain in the facial region in the last 6 months;
  • Presence of pain, at least 3 on the numeric pain scale (END), in the Temporomandibular Joint and/or masticatory muscles and in the last 6 months;
  • Diagnosis of myogenic Temporomandibular Disorder, by DC/TMD;
  • Moderate and Severe Temporomandibular Disorder carrier, according to Fonseca's Anamnestic Index;
  • Presence of Insufficiency of Convergence according to Convergence Test (TC) and by Convergence insufficiency symptom Survey (CISS).

Exclusion Criteria:

  • Permanent strabismus;
  • History of strabismus surgery;
  • History of cervical and/or craniofacial trauma/surgical procedure;
  • History of ocular nerve injury;
  • Neurological disorders;
  • disc disease ;
  • Systemic diseases;
  • Fibromyalgia diagnosis;
  • Previous treatments for TMD carried out in the last 3 months;
  • Previous treatments of Convergence Insufficiency with oculomotor therapy (no more than 2 months of treatment in the last year);
  • Occlusal treatment in progress;
  • Any ocular or systemic medication known to affect accommodation or vergence ;
  • Systemic diseases that affect ocular accommodation, vergence , and motility, such as multiple sclerosis, Graves' thyroid disease, myasthenia gravis, diabetes, and Parkinson's disease;
  • In continuous use of analgesics, anti-inflammatories, anxiolytics and/or antidepressants;
  • Pregnant women.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Oculomotor Therapy
The procedures for oculomotor therapy will be arranged sequentially, from easiest to most difficult. It will consist of a convergence technique (Brock Cord and Barrille Cartouche) and an accommodative technique (Eccentric circles or lifesaving cards) and Eye Relaxation.
It will consist exercise of a convergence technique and an accommodative technique.
Active Comparator: Therapy for Temporomandibular Disorder

Extra-oral and intra-oral massage: The main objective is to reduce pain as well as re-establish proper muscle length and flexibility. The patient will be instructed to use diaphragmatic breathing to promote relaxation during these massage procedures.

Myofascial release of the masseter, temporalis and sternocleidomastoid muscles, release of neck soft tissues, cervical pomp, suboccipital inhibition, passive anteroposterior mobilization of the upper cervical, cervical exercises, Temporomandibular Joint exercises (mouth opening exercise with tongue on palate) , Proprioceptive exercises).

It will consist exercise of a convergence technique and an accommodative technique.
It will consist exercise of a ATM and cervical spine.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Score in Numerical Pain Scale
Time Frame: The level of pain at 12 weeks
intensity of pain
The level of pain at 12 weeks
Score in Numerical Pain Scale
Time Frame: The level of pain at 3 months
intensity of pain
The level of pain at 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
measure range of motion
Time Frame: The range of motionat 12 weeks
range of motion
The range of motionat 12 weeks
measure range of motion
Time Frame: The range of motion at 3 months
range of motion
The range of motion at 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

February 27, 2023

First Submitted That Met QC Criteria

February 27, 2023

First Posted (Actual)

March 9, 2023

Study Record Updates

Last Update Posted (Actual)

March 6, 2024

Last Update Submitted That Met QC Criteria

March 5, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The data is confi dential, but if any journal requests open data for publication for sure we will provide our database

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temporomandibular Joint Disorders

Clinical Trials on Oculomotor Therapy

Subscribe